US Patent Litigations are now available. Check here

Explore Aventis Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2493466Mar 10, 2021Novel Antitumoral Use Of Cabazitaxel13
EP3294285Dec 18, 2019Cabazitaxel And Its Use For Treating Cancer9
EP2678011Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And Cisplatin1